close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Charles River Laboratories International, Inc. Common Stock (NY:CRL)

167.64 +5.56 (+3.43%)
Official Closing Price Updated: 4:10 PM EST, Nov 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Charles River Laboratories International, Inc. Common Stock

< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
News headline image
Charles River and Ziphius Vaccines Collaborate to Manufacture saRNA-Based Vaccine
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River and ASC Therapeutics to Scale Manufacturing of Second-Generation Gene Therapy for Hemophilia A
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories to Participate in Jefferies and William Blair Conferences
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Analyst Ratings for Charles River ↗
Within the last quarter, Charles River (NYSE:CRL) has observed the following analyst ratings: 
Via Benzinga
News headline image
Charles River: Q1 Earnings Insights ↗
Charles River (NYSE:CRL) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Recap: Charles River Q4 Earnings ↗
  Charles River (NYSE:CRL) reported its Q4 earnings results on Wednesday, February 16, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Charles River Laboratories Announces First-Quarter 2022 Results
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Earnings Scheduled For February 16, 2022 ↗
Companies Reporting Before The Bell • Wix.com (NASDAQ:WIX) is projected to report quarterly loss at $0.38 per share on revenue of $331.16 million. 
Via Benzinga
News headline image
Preview: Charles River's Earnings ↗
Charles River (NYSE:CRL) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that Charles River... 
Via Benzinga
News headline image
Charles River and Valo Launch Logica, an Integrated AI-Powered Drug Discovery Solution to Rapidly Deliver Optimized Preclinical Assets
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
3 Top S&P 500 Stock Market Gainers Today: Coronavirus Vaccine Maker Moderna Jumps ↗
Moderna led big-cap winners Monday. Oil services giants were losers. 
Via Investor's Business Daily
News headline image
Wells Fargo Maintains Overweight Rating for Charles River: Here's What You Need To Know ↗
Wells Fargo has decided to maintain its Overweight rating of Charles River (NYSE:CRL) and lower its price target from $390.00 to $325.00. Shares of Charles River are trading down 7.96% over the last 24... 
Via Benzinga
News headline image
What 6 Analyst Ratings Have To Say About Charles River ↗
Analysts have provided the following ratings for Charles River (NYSE:CRL) within the last quarter: 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2022 ↗
 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Monday ↗
Keybanc cut Salesforce, Inc. (NYSE: CRM) price target from $281 to $223. Salesforce shares fell 1.1% to $169.60 in pre-market trading. 
Via Benzinga
News headline image
Charles River Laboratories Schedules First-Quarter 2022 Earnings Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Publishes 2021 Corporate Citizenship Report
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For April 7, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Charles River Buys Contract Vivarium Research Services Firm In $295M Deal ↗
Charles River Laboratories International Inc (NYSE: CRL) has acquired Explora BioLabs Holdings Inc, a provider of contract vivarium research services,  
Via Benzinga
News headline image
Charles River Laboratories Acquires Explora BioLabs
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories to Appoint Flavia H. Pease as Chief Financial Officer
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Markets Fall Amid Rising Oil Prices ↗
U.S. indices finished lower Wednesday as investors continue to weigh the Federal Reserve tapering outlook, inflation concerns and the Russia-Ukraine war. Oil prices have also... 
Via Benzinga
News headline image
Inflation Beneficiary ETFs in Focus as Prices Soar ↗
Many experts predicted that inflation would cool off in spring as supply chains improve after pandemic-driven disruptions. It now appears that higher inflation could persist for longer. 
Via Talk Markets
News headline image
3 Moonshot Stocks Insiders Are Buying. What Do They Know? ↗
Biotech stocks aren't a sure thing, but one good sign is insiders buying up shares. These three all offer that enticing feature. 
Via InvestorPlace
News headline image
Charles River Earnings Perspective: Return On Invested Capital ↗
According to Benzinga Pro, during Q4, Charles River (NYSE:CRL) earned $139.83 million, a 32.97% increase from the preceding quarter. Charles River also posted a total of $905.05 million in sales, a... 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Thursday ↗
Cowen & Co. raised Yum! Brands, Inc. (NYSE: YUM) price target from $134 to $143. Yum! Brands shares fell 0.3% to $123.00 in pre-market trading. Keybanc cut the price target... 
Via Benzinga
News headline image
Charles River's Q4 Earnings Beats Street Expectation, Reaffirms FY22 Outlook ↗
Charles River Laboratories International Inc's (NYSE: CRL)  
Via Benzinga
News headline image
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2021 Results
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Announces Wind Contract with Repsol for European Operations
From Charles River Laboratories International, Inc.
Via Business Wire
< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today